Edition:
United States

PerkinElmer Inc (PKI.N)

PKI.N on New York Stock Exchange

77.84USD
15 Jun 2018
Change (% chg)

$-0.50 (-0.64%)
Prev Close
$78.34
Open
$77.74
Day's High
$78.25
Day's Low
$76.92
Volume
460,918
Avg. Vol
170,933
52-wk High
$84.42
52-wk Low
$62.43

Latest Key Developments (Source: Significant Developments)

PerkinElmer Appoints James Mock As Chief Financial Officer
Tuesday, 10 Apr 2018 04:30pm EDT 

April 10 (Reuters) - PerkinElmer Inc ::PERKINELMER APPOINTS JAMES MOCK AS CHIEF FINANCIAL OFFICER.PERKINELMER INC - ANDY WILSON WILL REMAIN WITH COMPANY AS AN ADVISOR FOR AN INTERIM PERIOD.  Full Article

Perkinelmer Inc reports Q3 adjusted earnings per share $0.73
Thursday, 2 Nov 2017 04:15pm EDT 

Nov 2 (Reuters) - Perkinelmer Inc :Perkinelmer Inc announces financial results for the third quarter of 2017.Q3 adjusted earnings per share $0.73.Q3 GAAP earnings per share $0.87 from continuing operations.Q3 revenue $554 million versus I/B/E/S view $552.5 million.Sees fy 2017 adjusted non-GAAP earnings per share $2.87 to $2.89.Sees fy 2017 GAAP earnings per share $2.55 to $2.57 from continuing operations.Q3 earnings per share view $0.72 -- Thomson Reuters I/B/E/S.Fy2017 earnings per share view $2.89 -- Thomson Reuters I/B/E/S.  Full Article

Phase II clinical trial data establishes effectiveness of child’s own cord blood treating cerebral palsy
Tuesday, 31 Oct 2017 04:15pm EDT 

Oct 31 (Reuters) - Perkinelmer Inc :Phase II clinical trial data establishes effectiveness of using a child’s own cord blood to treat cerebral palsy.  Full Article

PerkinElmer launches QSight210 MD system for clinical laboratories
Friday, 8 Sep 2017 08:15am EDT 

Sept 8 (Reuters) - Perkinelmer Inc :PerkinElmer Inc - launches QSight210 MD system for clinical laboratories.  Full Article

PerkinElmer enters into 364-day unsecured term loan facility
Tuesday, 15 Aug 2017 04:26pm EDT 

Aug 15 (Reuters) - PerkinElmer Inc ::PerkinElmer Inc - ‍on August 11, entered into a 364-day unsecured term loan facility in principal amount of $200 million - SEC filing​.PerkinElmer Inc - ‍term loans under facility are available from effective date until earliest of 3:00 P.M. New York City time on December 31, 2017​.PerkinElmer Inc - ‍on August 11, 2017, company entered into an amendment no. 1 to its existing credit agreement, dated August 11, 2016​.PerkinElmer Inc - ‍amendment amends revolving credit agreement to remove foreign currency sublimit under facility​.PerkinElmer Inc - ‍amendment to amend financial covenants to allow for higher consolidated leverage ratio through fiscal quarter ending July 1, 2018​.  Full Article

BRIEF-PerkinElmer launches clinical whole genome sequencing services
Friday, 4 Aug 2017 09:24am EDT 

Corrects thoughtout to PerkinElmer from Perkinelmer:PerkinElmer launches clinical whole genome sequencing services.Announced launch of PerkinElmer genetics' clinical genomics services.  Full Article

PerkinElmer reports Q2 GAAP EPS from continuing operations $0.57
Thursday, 3 Aug 2017 04:15pm EDT 

Aug 3 (Reuters) - PerkinElmer Inc ::Q2 GAAP earnings per share from continuing operations $0.57; Q2 adjusted earnings per share $0.67; Q2 GAAP revenue $547.0 million versus $536.2 million.Based on overall performance for H1, remain on track to deliver FY financial commitments.Sees FY GAAP earnings per share from continuing operations $2.23-$2.31; sees FY adjusted earnings per share $2.84-$2.92.Q2 earnings per share view $0.67, revenue view $554.0 million -- Thomson Reuters I/B/E/S.Fy2017 earnings per share view $2.86 -- Thomson Reuters I/B/E/S.  Full Article

Perkinelmer launches clinical whole genome sequencing services
Thursday, 3 Aug 2017 01:14pm EDT 

Aug 3 (Reuters) - Perkinelmer Inc :Perkinelmer launches clinical whole genome sequencing services.Announced launch of perkinelmer genetics' clinical genomics services.  Full Article

PerkinElmer to acquire Euroimmun for about $1.3 bln
Monday, 19 Jun 2017 03:00am EDT 

June 19 (Reuters) - PerkinElmer Inc ::PerkinElmer to acquire Euroimmun for approximately $1.3 billion.Agreement provides that perkinElmer will acquire up to a 100% stake in Euroimmun.Total purchase price of transaction based on all outstanding shares being acquired will be approximately $1.3 billion in cash.PerkinElmer Inc - acquisition is expected to be accretive to perkinelmer's 2018 non-gaap earnings per share results by approximately $0.28 to $0.30.Says PerkinElmer is reaffirming its 2017 revenue and earnings per share guidance.  Full Article

PerkinElmer reports Q1 GAAP earnings per share of $0.33
Thursday, 4 May 2017 04:15pm EDT 

May 4 (Reuters) - PerkinElmer Inc :PerkinElmer Inc says raises full year revenue and earnings per share guidance.Quarterly GAAP revenue of $514 million, an increase of 3%.Quarterly organic revenue increased 4%.Says Q1 GAAP earnings per share from continuing operations of $0.33, as compared to $0.38 in q1 of 2016.Quarterly adjusted earnings per share of $0.55.Q1 earnings per share view $0.54, revenue view $506.0 million -- Thomson Reuters I/B/E/S.Says for 2017, forecasts GAAP earnings per share from continuing operations in range of $2.16 to $2.26 .FY2017 earnings per share view $2.82 -- Thomson Reuters I/B/E/S.Sees 2017 adjusted earnings per share of $2.80 to $2.90.  Full Article

UPDATE 1-PerkinElmer raises 2018 forecasts as 1st-qtr profit beats Street

April 30 Laboratory equipment maker PerkinElmer posted a slightly higher-than-expected first-quarter profit on Monday and revised its full-year earnings forecast upward as sales grew in both of its business units.